Matches in Wikidata for { <http://www.wikidata.org/entity/Q91699532> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q91699532 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91699532 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91699532 description "scientific article published on 19 February 2019" @default.
- Q91699532 description "wetenschappelijk artikel" @default.
- Q91699532 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91699532 name "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 name "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 type Item @default.
- Q91699532 label "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 label "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 prefLabel "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 prefLabel "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 P1433 Q91699532-F131E381-3207-4895-8183-BF1219A7BD64 @default.
- Q91699532 P1476 Q91699532-082BD895-A69B-4757-9383-3A9C1A6C857E @default.
- Q91699532 P2093 Q91699532-24BB4BB8-B8E3-4B2E-9420-2519E57683B3 @default.
- Q91699532 P2093 Q91699532-5CB37EF3-AF01-4B80-ABA7-2998FE43B4BB @default.
- Q91699532 P2093 Q91699532-5ED9DE98-1279-41A3-8CB8-CF90B458EBCB @default.
- Q91699532 P2093 Q91699532-73831CA8-6709-4E43-85B8-5B04EC85AD85 @default.
- Q91699532 P2093 Q91699532-99AF12B5-DD4A-4B03-8661-FFD6BB70115C @default.
- Q91699532 P2093 Q91699532-BAB3AF41-EE0E-449D-BE2C-C7737A0EE105 @default.
- Q91699532 P2093 Q91699532-BCA6C41C-5833-49C1-A1C5-3EA02FA94319 @default.
- Q91699532 P2093 Q91699532-DA9596A6-9D0E-491F-9124-30F38317358D @default.
- Q91699532 P304 Q91699532-D4118C35-57CD-465E-817C-CB87C7971089 @default.
- Q91699532 P31 Q91699532-98804F3E-9BA0-40D6-9128-435B3CA0F9E1 @default.
- Q91699532 P356 Q91699532-BCF3D930-FE50-4E9C-98C8-29BC9CED58F9 @default.
- Q91699532 P433 Q91699532-87102A63-1FCA-44BC-AB10-C794EEFE09E9 @default.
- Q91699532 P478 Q91699532-2D44A6C5-6B20-44F9-BC08-1AD9CFE05757 @default.
- Q91699532 P577 Q91699532-331077E8-E01A-4FE2-930B-574471EFE13D @default.
- Q91699532 P698 Q91699532-75026E14-F269-4D13-862F-D0C7FD31482B @default.
- Q91699532 P921 Q91699532-340C591B-D0CF-4958-A465-73BCAD59579F @default.
- Q91699532 P356 NAU.23935 @default.
- Q91699532 P698 30779375 @default.
- Q91699532 P1433 Q15753354 @default.
- Q91699532 P1476 "Comparison in the efficacy of fesoterodine or mirabegron add-on therapy to silodosin for patients with benign prostatic hyperplasia complicated by overactive bladder: A randomized, prospective trial using urodynamic studies" @default.
- Q91699532 P2093 "Masashi Kato" @default.
- Q91699532 P2093 "Momokazu Gotoh" @default.
- Q91699532 P2093 "Naoto Sassa" @default.
- Q91699532 P2093 "Shun Takai" @default.
- Q91699532 P2093 "Tokunori Yamamoto" @default.
- Q91699532 P2093 "Tsuyoshi Majima" @default.
- Q91699532 P2093 "Yasuhito Funahashi" @default.
- Q91699532 P2093 "Yoshihisa Matsukawa" @default.
- Q91699532 P304 "941-949" @default.
- Q91699532 P31 Q13442814 @default.
- Q91699532 P356 "10.1002/NAU.23935" @default.
- Q91699532 P433 "3" @default.
- Q91699532 P478 "38" @default.
- Q91699532 P577 "2019-02-19T00:00:00Z" @default.
- Q91699532 P698 "30779375" @default.
- Q91699532 P921 Q506659 @default.